| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
23,910,000 |
| Market
Cap: |
2.39(B) |
| Last
Volume: |
165,174 |
Avg
Vol: |
186,425 |
| 52
Week Range: |
$81.08 - $209.15 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 789 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile ICU Medical is an infusion therapy company. Co. has four product lines: Infusion Consumables, which include Clave™ needlefree products, SwabCap and SwabTip disinfecting caps, ClearGuard HD antimicrobial barrier caps for hemodialysis catheters and Tego™ hemodialysis connector used to cap and protect hemodialysis central venous catheter hubs; Infusion Systems, which provide infusion pumps, dedicated IV sets, software and other services; IV Solutions, which provide a supply of IV solutions, irrigation and nutritionals; and Critical Care, which helps clinicians get real-time access to patients' hemodynamic and cardiac status with a portfolio of monitoring systems and sensors and catheters.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
25,835 |
| Total Buy Value |
$0 |
$0 |
$0 |
$4,467,256 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
1,731,983 |
1,733,712 |
1,800,756 |
1,804,487 |
| Total Sell Value |
$183,670,269 |
$183,822,465 |
$195,804,141 |
$196,491,165 |
| Total People Sold |
6 |
6 |
8 |
8 |
| Total Sell Transactions |
12 |
13 |
17 |
23 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jain Vivek |
Chairman and CEO |
• • – |
2024-02-12 |
4 |
OE |
$58.79 |
$3,880,140 |
I/I |
66,000 |
126,000 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2024-02-12 |
4 |
D |
$104.02 |
$8,605,055 |
D/D |
(82,725) |
87,318 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2024-02-12 |
4 |
OE |
$58.79 |
$8,604,857 |
D/D |
146,366 |
170,043 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2023-12-01 |
4 |
S |
$88.03 |
$152,196 |
D/D |
(1,729) |
9,877 |
|
-8% |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2023-09-08 |
4 |
S |
$128.97 |
$883,930 |
D/D |
(6,850) |
13,603 |
|
27% |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2023-07-12 |
4 |
AS |
$180.02 |
$5,400,720 |
D/D |
(30,000) |
23,677 |
|
-52% |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2023-07-12 |
4 |
OE |
$58.79 |
$1,763,700 |
D/D |
30,000 |
53,677 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2023-06-14 |
4 |
AS |
$185.73 |
$5,660,086 |
D/D |
(30,000) |
23,677 |
|
-43% |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2023-06-14 |
4 |
OE |
$58.79 |
$1,763,700 |
D/D |
30,000 |
25,881 |
|
- |
|
| Finney Elisha W |
Director |
– • – |
2023-06-07 |
4 |
AS |
$190.41 |
$36,940 |
D/D |
(194) |
1,481 |
|
-42% |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2023-06-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
85 |
23,677 |
|
- |
|
| Kennedy Kolleen T |
Director |
– • – |
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
485 |
614 |
|
- |
|
| Greenberg David C. |
Director |
– • – |
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
485 |
4,089 |
|
- |
|
| Hoffmeister David F |
Director |
– • – |
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
485 |
2,079 |
|
- |
|
| Abbey Donald |
Director |
– • – |
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
485 |
2,079 |
|
- |
|
| Finney Elisha W |
Director |
– • – |
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
485 |
1,675 |
|
- |
|
| Hernandez Laurie |
Director |
– • – |
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
485 |
937 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2023-04-11 |
4 |
AS |
$175.00 |
$43,750 |
D/D |
(250) |
4,678 |
|
-25% |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2023-04-05 |
4 |
AS |
$170.00 |
$77,860 |
D/D |
(458) |
4,928 |
|
-17% |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2023-03-08 |
4 |
D |
$156.17 |
$186,779 |
D/D |
(1,196) |
5,386 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2023-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,272 |
6,582 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2023-03-08 |
4 |
D |
$156.17 |
$181,626 |
D/D |
(1,163) |
20,453 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2023-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,209 |
21,616 |
|
- |
|
| Bonnell Brian Michael |
Chief Financial Officer |
• – – |
2023-03-08 |
4 |
D |
$156.17 |
$181,626 |
D/D |
(1,163) |
12,415 |
|
- |
|
| Bonnell Brian Michael |
Chief Financial Officer |
• – – |
2023-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,209 |
13,578 |
|
- |
|
1476 Records found
|
|
Page 3 of 60 |
|
|
0.95 (0.96%) 
